MarketInOut Stock Screener Log In | Sign Up

Kimia Biosciences Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Kimia Biosciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization1,465.28 mln
Float2.39 mln

EPS

1.52
Moderate

P / E

19.80
Moderately valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.3
Borderline

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

1.96
High leverage

Business Description

Kimia Biosciences Limited is an Indian pharmaceutical company based in New Delhi that produces and sells active pharmaceutical ingredients used in a wide range of medicines, from treatments for diabetes, heart conditions, and infections to products targeting mental health, respiratory issues, and skin care. Founded in 1993 and originally known as Laurel Organics Ltd, the company adopted its current name in January 2019. In addition to serving domestic customers, it also exports its products to international markets.

Key Fundamentals

EPS1.52
P/E19.80
ROE54.89
RPS24.99
ROIC13.67
ROA6.73
Interest Cover3.85
EBITDA, mln149
EV / EBITDA12.40
EV / EBIT17.06
Revenue, mln1,120
EV / Revenue1.65

Quote Details

Last 30.07
Change -0.76 (-2.47%)
Open 30.97
Volume 416
Turnover 12,509
Average Volume 3,327.81

Financial Ratios

Pre-Tax Profit Margin7
Current Ratio1.04
Price / Book8.55
Price / Tangible Book14.22
Debt / Equity1.96
Price / Sales1.35

Financial Strength

Altman Z-Score2.55
Piotroski F-Score 4 / 9
Beneish M-Score-2.3
Price to Graham Number3.59
Shiller PE Ratio34.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3% 53 / 100   
1 Month 2.63% 85 / 100   
2 Months -9.78% 44 / 100   
6 Months -18.09% 30 / 100   
1 Year -10.24% 60 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog